Arbutus to Present Imdusiran Data at EASL Congress 2024 : vi

WARMINSTER, Pa., May 22, 2024 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with...

Related Keywords

United States , Italy , Canada , Milan , Lombardia , Canadian , N Acetylgalactosamine Galnac , Kosh Agarwal , Fung Yuen , Lisam Caperelli , Arbutus Biopharma Corporation Nasdaq , Securities Exchange , World Health Organization , Biopharma Corporation , European Association , Poster Tour , Looking Statements , Securities Act , Securities Exchange Act , Arbutu Annual Report , Arbutu Quarterly Reports ,